The “PV/CVB” dot blotting assay was then used to analyze the purified monoclonal Igs of the 28 MGUS and 16 MM patients who presented with serum antibodies against the “PV1”, “PV3” or “CVB1/3” peptides. Here, PLVAP is linked to Miyoshi myopathy.